izpis_h1_title_alt

Attenuation of Nicotine Effects on A549 Lung Cancer Cells by Synthetic α7 nAChR Antagonists APS7-2 and APS8-2
ID Joukhan, Ahmad (Author), ID Kononenko, Veno (Author), ID Bele, Tadeja (Author), ID Sollner Dolenc, Marija (Author), ID Peigneur, Steve (Author), ID Lopes Pinheiro-Junior, Ernesto (Author), ID Tytgat, Jan (Author), ID Turk, Tom (Author), ID Križaj, Igor (Author), ID Drobne, Damjana (Author)

.pdfPDF - Presentation file, Download (6,98 MB)
MD5: 63E69A5A08CEF6DE779A2314CF654EC8
URLURL - Source URL, Visit https://www.mdpi.com/1660-3397/22/4/147 This link opens in a new window

Abstract
Nicotine binds to nicotinic acetylcholine receptors (nAChRs) that are overexpressed in different cancer cells, promoting tumor growth and resistance to chemotherapy. In this study, we aimed to investigate the potential of APS7-2 and APS8-2, synthetic analogs of a marine sponge toxin, to inhibit nicotine-mediated effects on A549 human lung cancer cells. Our electrophysiological measurements confirmed that APS7-2 and APS8-2 act as α7 nAChR antagonists. APS8-2 showed no cytotoxicity in A549 cells, while APS7-2 showed concentration-dependent cytotoxicity in A549 cells. The different cytotoxic responses of APS7-2 and APS8-2 emphasize the importance of the chemical structure in determining their cytotoxicity on cancer cells. Nicotine-mediated effects include increased cell viability and proliferation, elevated intracellular calcium levels, and reduced cisplatin-induced cytotoxicity and reactive oxygen species production (ROS) in A549 cells. These effects of nicotine were effectively attenuated by APS8-2, whereas APS7-2 was less effective. Our results suggest that APS8-2 is a promising new therapeutic agent in the chemotherapy of lung cancer.

Language:English
Keywords:marine toxin, nicotinic acetylcholine receptor, nAChR antagonist, APS7-2, APS8-2
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
BF - Biotechnical Faculty
Publication status:Published
Publication version:Version of Record
Year:2024
Number of pages:14 str.
Numbering:Vol. 22, iss. 4
PID:20.500.12556/RUL-155641 This link opens in a new window
UDC:615.9:616.24-006
ISSN on article:1660-3397
DOI:10.3390/md22040147 This link opens in a new window
COBISS.SI-ID:190758147 This link opens in a new window
Publication date in RUL:09.04.2024
Views:382
Downloads:34
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Marine drugs
Shortened title:Mar. drugs
Publisher:MDPI
ISSN:1660-3397
COBISS.SI-ID:23578841 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:rak (medicina), toksičnost, morski toksini, nikotinski acetilholinski receptor, antagonist nAChR, APS7-2, APS8-2

Projects

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J4-4550
Name:Raziskave medvrstnih in znotraj vrstnih bakterijskih interakcij za izboljšanje probiotika z in vitro in in vivo modelnimi sistemi

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J2-3052
Name:Inženiring inovativnih in pametnih hibridnih materialov prihodnosti z združevanjem laserskofunkcionaliziranih kovinskih površin in živih celic (LaserInSMArT)

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-2520
Name:Ugotavljanje pojava, vzroka in škodljivih učinkov oksidativnega stresa induciranega zaradi uporabe nesnemnih ortodontskih aparatov

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0207
Name:Toksini in biomembrane

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P2-0424
Name:Dizajn novih lastnosti (nano)materialov & aplikacije

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:Z1-2634
Name:Nanodostavni sistemi antagonistov nAChR za razvoj nove strategije zdravljenja raka pljuč

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:1000-19-0106

Funder:Other - Other funder or multiple funders
Funding programme:F.W.O.-Vlaanderen
Project number:12W7822N

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back